drugset / Trial / NCT05560516
Qutenza Versus Duloxetine in Chemotherapy-induced Peripheral Neuropathy (CIPN)
Unknown
102 enrolled
Academic Medical Center - University of Amsterdam
Leiden University Medical Center · collabReinier de Graaf Groep · collab
RandomizedParallel-groupSingle-blindTreatment
Summary
The primary objective is to determine whether in patients with CIPN pain, treatment with Qutenza has the same effect as treatment with duloxetine 60 mg daily.
Timeline
- Start
- 2022-12-01
- Primary completion
- 2024-12-31
- Completion
- 2025-12-31
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Capsaicin | Small molecule | 8 % | Topical |
| Subject | Capsaicin | Small molecule | 179 mg | Topical |
| Comparator | Duloxetine | Small molecule | 60 mg | — |